Archive | TAmiRNA GmbH

Page 4 of 6
TAmiRNA joins multinational TransBioLine biomarker research project
TAmiRNA joins multinational TransBioLine biomarker research project Learn More >
TAmiRNA brings new miRNA insights to ECTS Budapest
TAmiRNA brings new miRNA insights to ECTS Budapest Learn More >
TAmiRNA showcases thrombomiRâ„¢ microRNA platelet testing kit at GTH 2019 Berlin
TAmiRNA showcases thrombomiRâ„¢ microRNA platelet testing kit at GTH 2019 Berlin Learn More >
TAmiRNA experts to speak at Austrian Bone Conference in Vienna
TAmiRNA experts to speak at Austrian Bone Conference in Vienna Learn More >
Web-based tools collection for microRNA analysis
Web-based tools collection for microRNA analysis Learn More >
TAmiRNA presenting microRNA cardiovascular applications at Eurothrombosis 2018
TAmiRNA presenting microRNA cardiovascular applications at Eurothrombosis 2018 Learn More >
TAmiRNA showing advanced fracture risk diagnosis at ASBMR Montreal
TAmiRNA showing advanced fracture risk diagnosis at ASBMR Montreal Learn More >
Cell-type specific microRNA/mRNA analysis in complex tissues
Cell-type specific microRNA/mRNA analysis in complex tissues Learn More >
TAmiRNA and Vivomicx revolutionize drug discovery with cell-type specific microRNA/mRNA analysis protocols
TAmiRNA and Vivomicx revolutionize drug discovery with cell-type specific microRNA/mRNA analysis protocols Learn More >
45764Circulating platelet-derived thrombomiRs as non-invasive biomarkers in P2Y12 anti-platelet therapy
Circulating platelet-derived thrombomiRs as non-invasive biomarkers in P2Y12 anti-platelet therapy Learn More >
TAmiRNA presents microRNA bone disease applications at MolPharm 2018
TAmiRNA presents microRNA bone disease applications at MolPharm 2018 Learn More >
TAmiRNA brings new musculoskeletal insights to ECTS 2018
TAmiRNA brings new musculoskeletal insights to ECTS 2018 Learn More >
Page 4 of 6